Nasdaq announces that trading in Faron Pharmaceuticals Oy shares (short name: FARON) commence on December 3, 2019 on Nasdaq First North Growth Market Finland.
Sisu Partners advised Faron Pharmaceuticals on the dual listing and continues to act as the company’s Certified Adviser.